Verona Pharma Inc. (VRNA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Verona Pharma plc (VRNA) rivojlanishi innovatsion COPD davolash vositasi Ohtuvayre ning bozorga chiqarilishi va sanoat gigantlari bilan birlashish istiqbollariga bog'liq. separate_debt_long_eq metriki uchun narx harakati 0.81 ni tashkil etadi, bu esa global beqarorlik fonida ta'minot zanjirining uzilishi xavflari va patent himoyasining murakkabliklari bilan mos keladi. Hozirgi vaqtda biznesning taqdiri yangi o'pka mahsulotining sotuv samaradorligi va distribyutorlarning faoliyatiga bog'liq.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_VRNA_-_Verona-Pharma-plc_-_Long-Term-Debt-to-Capital "VRNA: Verona Pharma Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 18.10.2025 | 👁️GURU.Markets👁️")
Verona Pharma plc (VRNA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Verona Pharma plc|VRNA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati veronapharma.com|VRNA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Verona Pharma plc|VRNA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Verona Pharma|Oraliq likvidlik koeffitsiyenti veronapharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Verona Pharma PLC - VRNA
Ushbu ko'rsatkich biznesning to'lov qobiliyatini tahlil qilish uchun uzoq muddatli majburiyatlarning kapitalga nisbatini aniqlash orqali moliyaviy leverajni baholaydi. Bir yildan ortiq muddatli kreditlarning kapitalga nisbatidagi ko'rsatkichi tendentsiyasi Verona Pharma plc (VRNA) kompaniyasining tashqi moliyalashtirishga bog'liqlik darajasini namoyish etadi, bu esa asosiy dori vositasining bozorga chiqarilishi davridagi kutilmagan pul oqimlarini hisobga olganda juda muhimdir.
Raqobatdosh kompaniyalar tahlili
Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|MENS (Jyong Bio) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati LGND (Ligand Pharmaceuticals)|Uzoq muddatli qarzning kapitalga nisbati amneal.com AMRX|PRGO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Galapagos Corp|ANIP (ANI Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati mannkindcorp.com|Uzoq muddatli qarzning o'z kapitaliga nisbati AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ARS Pharma SPRY|Theravance Corp (TBPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AQST: Uzoq muddatli qarzning o'z kapitaliga nisbati|scPharmaceuticals Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|TECX: Uzoq muddatli qarzning kapitalga nisbati|Tonix Pharma - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SXTC (SXT Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eupraxia Pharma EPRX|Uzoq muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Oramed Pharmaceuticals Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Entera Bio Ltd - Uzoq muddatli qarzning o'z kapitaliga nisbati|MindWalk - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ABVC BioPharma, Inc|Cumberland Pharmaceuticals (CPIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|quantumbiopharma.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati FibroGen|Uzoq muddatli majburiyatlarning kapitalga nisbati Telomir Pharmaceuticals Inc TELO|Uzoq muddatli qarzning o'z kapitaliga nisbati Rani Therapeutics (RANI)|synergychc.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RLYB (Rallybio)|Uzoq muddatli qarzning kapitalga nisbati Lexaria Bioscience Corp LEXX|PULM: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PTHL (Pheton Holdings Ltd)|aptorumgroup.com (APM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati LYRA (Lyra Therapeutics Inc)|IBO (Impact BioMedical Inc) - Uzoq muddatli qarzning kapitalga nisbati|TNFA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati YCBD|Uzoq muddatli qarzning kapitalga nisbati PainReform Ltd (PRFX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Altamira Therapeutics Ltd. CYTO|Uzoq muddatli qarzning kapitalga koeffitsiyenti LIPO|OPTN - Uzoq muddatli qarzning o'z kapitaliga nisbati|pieris.com (PIRS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PROC: Uzoq muddatli qarzning kapitalga nisbati|Petros Pharmaceuticals Inc (PTPI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati QLI|SLRN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati TFF Pharmaceuticals (TFFP)